Clinical role of atrial arrhythmias in patients with arrhythmogenic right ventricular dysplasia

Circulation Journal

Volumn 78, Issue 12, 2014, Pages 2854-2861

  Saguner, Ardan M ^a   Ganahl, Sabrina ^a   Kraus, Andrea ^b   Baldinger, Samuel H ^c   Medeiros Domingo, Argelia ^a,c   Saguner, Arhan R ^a   Mueller Burri, Stephan A ^d   Wolber, Thomas ^a,e   Haegeli, Laurent M ^a   Krasniqi, Nazmi ^a   Tanner, Felix C ^a,e   Steffel, Jan ^a   Brunckhorst, Corinna ^a   Duru, Firat ^a,e  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

^d TRIEMLI HOSPITAL   (Switzerland)

^e UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Arrhythmogenic right ventricular dysplasia; Atrial fibrillation; Atrial flutter; Cardiomyopathy

Indexed keywords

ADULT; ANTICOAGULATION; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOGENIC SHOCK; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR PARAMETERS; CATHETER ABLATION; DIASTOLIC BLOOD PRESSURE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE DYSPLASIA; HEART TRANSPLANTATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; SUDDEN CARDIAC DEATH; SURVIVAL; SYSTOLIC BLOOD PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; ATRIAL FIBRILLATION; ATRIAL FLUTTER; CLINICAL TRIAL; COMPLICATION; ECHOCARDIOGRAPHY; ECHOGRAPHY; EPIDEMIOLOGY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PREVALENCE; REGISTER; SWITZERLAND;

ADULT; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; ATRIAL FIBRILLATION; ATRIAL FLUTTER; DEFIBRILLATORS, IMPLANTABLE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PREVALENCE; REGISTRIES; SWITZERLAND;

EID: 84911868915     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-14-0474     Document Type: Article

References (34)

1. Fressart V, Duthoit G, Donal E, Probst V, Deharo JC, Chevalier P, et al. Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: Spectrum of mutations and clinical impact in practice. Europace 2010; 12: 861-868.
2. Nava A, Thiene G, Canciani B, Scognamiglio R, Daliento L, Buja G, et al. Familial occurrence of right ventricular dysplasia: A study involving nine families. J Am Coll Cardiol 1988; 12: 1222-1228.
3. Zhang M, Tavora F, Oliveira JB, Li L, Franco M, Fowler D, et al. PKP2 mutations in sudden death from arrhythmogenic right ventricular cardiomyopathy (ARVC) and sudden unexpected death with negative autopsy (SUDNA). Circ J 2012; 76: 189-194.
4. Kim C, Wong J, Wen J, Wang S, Wang C, Spiering S, et al. Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs. Nature 2013; 494: 105-110.
5. Chu AF, Zado E, Marchlinski FE. Atrial arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and ventricular tachycardia. Am J Cardiol 2010; 106: 720-722.
6. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991; 22: 983-988.
7. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation 1998; 98: 946-952.
8. Tonet JL, Castro-Miranda R, Iwa T, Poulain F, Frank R, Fontaine GH. Frequency of supraventricular tachyarrhythmias in arrhythmogenic right ventricular dysplasia. Am J Cardiol 1991; 67: 1153.
9. Brembilla-Perrot B, Jacquemin L, Houplon P, Houriez P, Beurrier D, Berder V, et al. Increased atrial vulnerability in arrhythmogenic right ventricular disease. Am Heart J 1998; 135: 748-754.
10. Camm CF, James CA, Tichnell C, Murray B, Bhonsale A, te Riele AS, et al. Prevalence of atrial arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Heart Rhythm 2013; 10: 1661-1668.
11. Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: Proposed modification of the Task Force Criteria. Eur Heart J 2010; 31: 806-814.
12. Roten L, Derval N, Sacher F, Pascale P, Scherr D, Komatsu Y, et al. Heterogeneous response of J-wave syndromes to beta-adrenergic stimulation. Heart Rhythm 2012; 9: 1970-1976.
13. Dilaveris PE, Gialafos EJ, Sideris SK, Theopistou AM, Andrikopoulos GK, Kyriakidis M, et al. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 1998; 135: 733-738.
14. Tsao CW, Josephson ME, Hauser TH, O'Halloran TD, Agarwal A, Manning WJ, et al. Accuracy of electrocardiographic criteria for atrial enlargement: Validation with cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2008; 10: 7.
15. Surawicz B, Childers R, Deal BJ, Gettes LS, Bailey JJ, Gorgels A, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram. Part III: Intraventricular conduction disturbances: A scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol 2009; 53: 976-981.
16. Amasyali B, Kose S, Aytemir K, Kilic A, Turhan H, Celik T, et al. P wave dispersion predicts recurrence of paroxysmal atrial fibrillation in patients with atrioventricular nodal reentrant tachycardia treated with radiofrequency catheter ablation. Ann Noninvasive Elec-trocardiol 2006; 11: 263-270.
17. Namdar M, Steffel J, Vidovic M, Brunckhorst CB, Holzmeister J, Luscher TF, et al. Electrocardiographic changes in early recognition of Fabry disease. Heart 2011; 97: 485-490.
18. De Bacquer D, Willekens J, De Backer G. Long-term prognostic value of p-wave characteristics for the development of atrial fibrillation in subjects aged 55 to 74 years at baseline. Am J Cardiol 2007; 100: 850-854.
19. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006; 7: 79-108.
20. Lemola K, Brunckhorst C, Helfenstein U, Oechslin E, Jenni R, Duru F. Predictors of adverse outcome in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: Long term experience of a tertiary care centre. Heart 2005; 91: 1167-1172.
21. D'Oronzio U, Senn O, Biaggi P, Gruner C, Jenni R, Tanner FC, et al. Right heart assessment by echocardiography: Gender and body size matters. J Am Soc Echocardiogr 2012; 25: 1251-1258.
22. Saguner AM, Vecchiati A, Baldinger SH, Rueger S, Medeiros-Domingo A, Mueller-Burri AS, et al. Different prognostic value of functional right ventricular parameters in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circ Cardiovasc Imaging 2014; 7: 230-239.
23. Saguner AM, Medeiros-Domingo A, Schwyzer MA, On CJ, Haegeli LM, Wolber T, et al. Usefulness of inducible ventricular tachycardia to predict long-term adverse outcomes in arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol 2012; 111: 250-257.
24. Grimm W, Flores BF, Marchlinski FE. Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol 1992; 15: 1667-1673.
25. Morady F, Shen EN, Scheinman MM. Unusual features of arrhythmogenic right ventricular dysplasia. Am J Cardiol 1984; 53: 639-640.
26. Jaoude SA, Leclercq JF, Coumel P. Progressive ECG changes in arrhythmogenic right ventricular disease: evidence for an evolving disease. Eur Heart J 1996; 17: 1717-1722.
27. Dogan U, Dogan EA, Tekinalp M, Tokgoz OS, Aribas A, Akilli H, et al. P-wave dispersion for predicting paroxysmal atrial fibrillation in acute ischemic stroke. Int J Med Sci 2012; 9: 108-114.
28. Lee KS, Appleton CP, Lester SJ, Adam TJ, Hurst RT, Moreno CA, et al. Relation of electrocardiographic criteria for left atrial enlargement to two-dimensional echocardiographic left atrial volume measurements. Am J Cardiol 2007; 99: 113-118.
29. Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Herpen G, Stricker BH, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: The Rotterdam study. Eur Heart J 2006; 27: 949-953.
30. Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation 1994; 89: 724-730.
31. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 1995; 98: 476-484.
32. Brook RD, Appel LJ, Rubenfire M, Ogedegbe G, Bisognano JD, Elliott WJ, et al. Beyond medications and diet: Alternative approaches to lowering blood pressure: A scientific statement from the american heart association. Hypertension 2013; 61: 1360-1383.
33. Nakajima T, Kaneko Y, Irie T, Takahashi R, Kato T, Iijima T, et al. Compound and digenic heterozygosity in desmosome genes as a cause of arrhythmogenic right ventricular cardiomyopathy in Japanese patients. Circ J 2012; 76: 737-743.
34. Ohno S, Nagaoka I, Fukuyama M, Kimura H, Itoh H, Makiyama T, et al. Age-dependent clinical and genetic characteristics in Japanese patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circ J 2013; 77: 1534-1542.